Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Annals of the Rheumatic Diseases
|
January 27, 2017
Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
J B Lilleker, A Rietveld, S R Pye, et al.
Neurology
|
July 3, 2020
Minimal manifestation status and prednisone withdrawal in the MGTX trial
Ikjae Lee, Hui-Chien Kuo, Inmaculada B Aban, et al.
The New England Journal of Medicine
|
August 11, 2016
Randomized Trial of Thymectomy in Myasthenia Gravis
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
The Lancet. Neurology
|
January 30, 2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Annals of the Rheumatic Diseases
|
January 27, 2017
Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
J B Lilleker, A Rietveld, S R Pye, et al.
Neurology
|
July 3, 2020
Minimal manifestation status and prednisone withdrawal in the MGTX trial
Ikjae Lee, Hui-Chien Kuo, Inmaculada B Aban, et al.
The New England Journal of Medicine
|
August 11, 2016
Randomized Trial of Thymectomy in Myasthenia Gravis
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
The Lancet. Neurology
|
January 30, 2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
Page
of 6